Nov 24, 2020|
JD Health and CTTQ to Explore Cooperation On Pharmaceutical Industry
by Hui Zhang
JD Health signed an agreement with Nanjing Chia Tai Tianqing Pharmaceutical (CTTQ) on November 23rd to establish cooperation in pharmaceutical supply chain, Internet hospital and pharmaceutical poverty alleviation.
Leveraging its supply chain advantage, JD Health will help CTTQ better reach downstream pharmaceutical stores through its B2B business, JD Medicine Procurement．The platform is of the largest third-party pharmaceutical wholesale platforms in China. Through JD’s pharmacy business, CTTQ will have access to JD’s over 440 million active users and will bring them high-quality drugs. CTTQ will also share its professional physician resources with JD Health so as to provide professional medical advice to patients, especially on cardiovascular disease.
Both sides will initiate public welfare programs in the near future to provide subsidies on drugs for cardiovascular disease treatment, and provide free consultations as well.
“JD Health will open its capabilities in areas such as pharmaceutical supply chain, Internet hospital, health management, and intelligent medical development to provide better, more convenient, efficient and safer pharmaceutical health services for all users,” said Xinyuan Zhou, head of JD Pharmaceutical Procurement and general manager of Channel Innovation at JD Health.
CTTQ, founded in 1969, is a multinational pharmaceutical company with integrated R&D, manufacturing, marketing, sales and distribution capabilities. It is ranked 16th on the list of the “Top 100 Pharmaceutical Enterprises in China” in 2019, and among the top 5 most innovative Pharmaceutical Enterprises, and top 10 fastest-growing pharmaceutical manufacturers in China.